Fruquin

Fruquin uses and dosage

Fruquin (Fruquintinib), generic Fruzaqla is a prescription medicine used to treat adults with metastatic colorectal cancer (mCRC) who have previously received fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy, an anti-VEGF therapy, and—if RAS wild-type and clinically appropriate—an anti-EGFR therapy. Fruquin manufactured by Everest Pharma Ltd. in Bangladesh. Fruquintinib has to take orally once daily for 21 days with or without food as directed by patient doctor.

Fruquin side effects

The most common adverse reactions of Fruquintinib are: Hypertension, Hand–foot skin reactions, Proteinuria, Dysphonia, Abdominal pain, Diarrhea, Asthenia.

Originator brand

Fruzaqla by Takeda Pharmaceuticals U.S.A., Inc

Made by

Everest Pharma

This information is provided for reference only and is not medical advice. Always consult a qualified healthcare professional.